Abivax
FranceWho owns Abivax?
Abivax is a French Biotech company, currently owned by Andera Partners since 2023 and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
Ownership history
3 ownership periods · co-invest detected · 1 lender on file
More from BioDiscovery 6
Other portfolio companies in the same fund.
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Abivax?
Abivax is currently owned by Andera Partners, Sofinnova Partners and 1 other, through BioDiscovery 6, since 2023.
When did Andera Partners and 2 others acquire Abivax?
Andera Partners and 2 others acquired Abivax in 2023.
Who has owned Abivax over time?
Abivax has been through 4 private-equity ownership periods: Truffle Capital · via Truffle Capital Legacy (pre-2019) · since 2013; Sofinnova Partners · via Sofinnova Crossover Fund I · since 2018; Claret Capital Partners · via Claret European Growth Capital Fund III · since 2023; Andera Partners · via BioDiscovery 6 · since 2023.